Hemolens Diagnostics

Hemolens Diagnostics Hemolens Diagnostics is a Polish venture which specializes in cardiac diagnostics. Each year almost 18 million people die from Coronary Artery Disease.

It’s now the number one cause of death Worldwide. But the problem lies also in Cardiac Diagnostics. The current diagnostic pathway is very long, expensive, and still not accurate enough. Because of that almost 30% of patients are sent home with their undetected disease. Unnecessary invasive coronary angiographies increase costs and waiting times. Our team consisting of bioengineers, cardiologists,

and ICT professionals has created an innovative, non-invasive method of identifying atherosclerosis.

🚨 We’re excited to announce that Bernard Gołko, CEO at Hemolens Diagnostics, will take the stage at the unique event IT ...
17/04/2026

🚨 We’re excited to announce that Bernard Gołko, CEO at Hemolens Diagnostics, will take the stage at the unique event IT UNPLUGGED, taking place on 17 June in Lublin.

He will raise the issue of ‘How to hack time? Digital cardiology as the key to the most profitable market of the future, focusing on current global problems within:
🔹 Aging of society ,
🔹 The growing importance of health, with a focus on cardiovascular diseases 🫀 as a leading cause of premature death,
🔹 The increasing strain on healthcare systems,
🔹 The urgent need for digital health transformation,
🔹 How can modern innovative technologies help in this area?

This special meeting brings together top Polish speakers across industries, creating a space for IT leaders, managers, and specialists who expect more - fresh perspectives, real-life case studies, and actionable solutions to stay ahead of the competition.

Save the date! 📅 17 June 2026 | 📍 Lublin

Secure your spot now 👉 https://it-unplugged.com/

Stay tuned for more details!



Big news! We're thrilled to welcome Bernard Gołko as our new Chief Executive Officer at Hemolens Diagnostics! 👏 Bernar...
14/04/2026

Big news! We're thrilled to welcome Bernard Gołko as our new Chief Executive Officer at Hemolens Diagnostics! 👏

Bernard brings over 10 years of experience in the medtech and financial sectors, as well as extensive experience as an investor in venture capital and in scaling innovative technology companies.

Previously, also in the role of CEO, he developed certified neurostimulation devices and a therapeutic platform that combines VR with neuromodulation, aimed, among other things, at patients with neurodegenerative diseases.

He is a co-creator of the AgeTech Polska initiative and the AgeTech.pl platform - one of Poland’s key hubs for knowledge and debate on technologies supporting healthy aging and the longevity economy. He also lectured at the Polish-Japanese Academy of Information Technology, sharing his expertise in innovation and technology entrepreneurship.

Beyond the world of tech and business, Bernard is passionate about long-distance enduro travels, music, and self-development.

Welcome aboard, Bernard! 👋



Innovation isn’t a slogan - it’s something that’s happening now 🚀. We are proud to share that Hemolens Diagnostics’ pat...
08/04/2026

Innovation isn’t a slogan - it’s something that’s happening now 🚀.

We are proud to share that Hemolens Diagnostics’ patent application has been named a Quartus 2026 laureate - an award that recognizes creators of inventions submitted for patent protection.

The prized application concerned a method for processing continuous non-invasive arterial blood pressure signals🩸🫀. The author of the awarded patent is Bartosz Olszewski, BME Engineer at Hemolens Diagnostics, in collaboration with PhD in Engineering, Cyprian Mataczyński, and PhD, Habilitation in Engineering, Magdalena Kasprowicz, Head of the BrainLab research group.

The winning application was submitted jointly with Wrocław University of Science and Technology (Politechnika Wrocławska) as part of the PhD Program, where Bartosz Olszewski attends.

This distinction underscores a powerful truth - when business and science join forces, they don’t just innovate; they redefine what’s possible and reshape the world around us 🦾. That’s why at Hemolens Diagnostics, we strongly believe in academic cooperation.

Congratulations to all involved! 👏🏻



Wishing you a joyful and peaceful Season! 🐣🌿 May the upcoming Easter Break bring you new opportunities, continued growth...
02/04/2026

Wishing you a joyful and peaceful Season! 🐣🌿

May the upcoming Easter Break bring you new opportunities, continued growth, inspiration, and fulfilment in all that you do.

Thank you for being part of our cardiac diagnostic journey🫀. Wishing you all the best in the season ahead!



25/03/2026

CCTA is now first-line for diagnosing coronary artery disease (CAD) 🫀 - is your workflow keeping up?

The new e-book, based on interviews with European radiologists, focuses on practical insights rather than general theory. It provides a hands-on guide built around the expectations and experiences of your peers. The report highlights the benefits of CCTA, such as reducing diagnostic time by 54% and lowering care costs by 35%, while also identifying key gaps in current image analysis platforms.

💡 What will you learn from the report?
1. What are the biggest challenges radiologists face in the current CCTA reporting workflow?
2. How does AI support the diagnosis of coronary artery disease?
3. Why is diagram-based reporting better than traditional text reports?
Don’t let a lack of technology limit your diagnostic potential. Discover what modern CCTA analysis tools should look like, and how they can genuinely support radiologists and cardiologists in everyday clinical practice

👉 Download the e-book: https://eu1.hubs.ly/H0sXV6z0

🚀 Something big is coming - the world’s #1 hospital recognizes Hemolens Diagnostics’ impact! We’re thrilled to announc...
12/03/2026

🚀 Something big is coming - the world’s #1 hospital recognizes Hemolens Diagnostics’ impact!

We’re thrilled to announce that we will be participating in The Second Annual Mayo Clinic Cardiology & Radiology Innovation Summit, taking place on June 11, 2026, in Rochester, Minnesota, United States. The event is organized by Mayo Clinic, which is ranked as the number one of World’s Best Hospitals 2026 ranking.

The upcoming Summit is an invitation-only event, and our company was selected after an advanced global process, including Mayo Clinic’s internal vetting to ensure strategic alignment and clinical impact. Only less than 100 startups and investors worldwide earned this opportunity. 🌎

The summit brings together top clinicians, innovators, and investors driving breakthroughs in cardiology and radiology, with a focus on technologies that truly transform patient care. As a company developing technologies for non-invasive cardiac diagnostics, we at Hemolens Diagnostics are excited to engage with leaders shaping the future of heart health and discuss how our solutions can contribute to advancing cardiac diagnostics internationally. 🫀

A huge thank you to Mayo Clinic and Mayo Clinic Business Development, and to the clinical and business development teams who supported us along the way.

👀 More details coming soon - stay tuned.



💐 On International Women’s Day, we celebrate what makes women truly exceptional - their sensitivity, strength, and const...
08/03/2026

💐 On International Women’s Day, we celebrate what makes women truly exceptional - their sensitivity, strength, and constant care for every aspect of life. Today, however, we would like to draw attention to something that is not always visible at first glance - heart health 🫀.

In the rush of everyday life, it’s easy to put your own health last. And the heart doesn’t always shout when something is wrong - sometimes it whispers through fatigue, shortness of breath, or pressure in the chest. Symptoms are often dismissed as stress or exhaustion.

That’s why awareness matters. Prevention, knowledge, and focus on early signals can save lives.

That is why today, we wish all women not only happiness, success, and satisfaction, but also strong hearts, peace of mind, and lasting health 💙 All the best! 🌷

24/02/2026

💡 Calling all proactive cardiologists!

🔍 On International EBM Day, we celebrate the power of Evidence-Based Medicine. Using the best scientific evidence alongside clinical expertise isn’t just theory - it’s crucial in non-invasive cardiac diagnostics, where precise, data-driven decisions can improve patient outcomes and guide personalized treatment 🫀. What if you could not only use evidence… but also create it?

🚀 Join the Cardiolens Evidence Lab – a unique program for physicians researching non-invasive cardiac diagnostics who want to present at top international conferences. If you want to:
• Conduct pilot clinical projects
• Analyze real-world data (RWD)
• Explore advanced CCTA & hemodynamic modeling
• And present your findings at major international congresses.

We provide:
✔️ Access to specialized CCTA & modeling tools
✔️ Methodological and editorial support (abstracts, case reports, manuscripts)
✔️ Coverage of publication fees
✔️ Financial support for conference participation (after acceptance).

If you're building your academic path, preparing your first abstract, or looking to strengthen your research portfolio - this is your moment!

Turn your research into impact – apply now 👉 https://eu1.hubs.ly/H0s26cc0

21/02/2026

But here’s the real question after PTK Conference in Wroclaw (PL): can we truly afford to resist change? Can we ignore what AI is already bringing to medicine? The future isn’t about rejecting technology - it’s about using it wisely, critically, and responsibly.
Huge thanks to the organizers for consistently raising the bar in cardiovascular education and boldly creating space for innovation.👏

21/02/2026

Absolutely inspired after attending the Wrocław PTK Conference! The dedication and intellectual generosity of the speakers in advancing cardiovascular education were truly outstanding.

A special highlight was the session 'Artificial Intelligence in the Service of Medicine' led by Tomasz Roleder and Adrian Doroszkiewicz - from Jan Kocoń’s insights on Polish LLMs in healthcare, through practical perspectives on AI implementation by Tomasz Roleder, to groundbreaking talks by Agnieszka Siennicka, Kamil Hudaszek, and Dariusz Jagielski on AI in patient education and electrophysiology - this was a powerful glimpse into the future of cardiology.

20/02/2026

Day 1 of the PTK Conference in Wrocław (Polish Cardiac Society) is behind us - packed with high-value insights on cardiac CT and hands-on Cardiolens Viewer image analysis workshops led by Prof. Tomasz Roleder!

Up next: Prof. Roleder’s lecture on implementing AI in healthcare - join us on site and don’t miss an inspiring Day 2 ahead!

18/02/2026

📢 We’re thrilled to introduce our next presenter at EAPCI Summit 2026 – Jakub Kuć, Medical Data Processing Manager at Hemolens Diagnostics.

Already this week (19–20 February), we’ll be joining the EAPCI Summit 2026 in Munich - one of the most important events in interventional cardiology, focused on translating the latest and most exciting evidence in the field into real-world clinical practice.

Don’t miss our upcoming e-poster speech: “Photon-counting CT improves coronary arteries lumen interpretation where it matters most”, featured in the session “Non-invasive imaging of the coronary arteries.”

During the presentation, Prof. Mariusz Kruk, MD, PhD, and Jakub Kuć will discuss how innovations in non-invasive coronary imaging can enable cardiologists to make more accurate and evidence-based clinical decisions.

Save the date! 🗓 20 February 🕙 10:45 AM📍 Munich, Germany

Let’s connect at EAPCI Summit 2026 and shape the future of non-invasive cardiac diagnostics together. 🚀🫀



Adres

Legnicka 48G
Wroclaw
54-202

Strona Internetowa

Ostrzeżenia

Bądź na bieżąco i daj nam wysłać e-mail, gdy Hemolens Diagnostics umieści wiadomości i promocje. Twój adres e-mail nie zostanie wykorzystany do żadnego innego celu i możesz zrezygnować z subskrypcji w dowolnym momencie.

Skontaktuj Się Z Firmę

Wyślij wiadomość do Hemolens Diagnostics:

Skróty

Udostępnij

Kategoria